Related Experiment Video
Updated: Mar 2, 2026

13:10
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
10.4K
Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke.
Maarten G Lansberg1, Soren Christensen1, Stephanie Kemp1
1Department of Neurology, Stanford University, Stanford, CA.
Annals of Neurology
|May 10, 2017
Summary
Computed tomographic (CT) perfusion helps identify acute stroke patients who benefit from endovascular therapy up to 18 hours after symptom onset. The "target mismatch" profile on CT perfusion indicates a higher likelihood of successful reperfusion and improved clinical outcomes.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Acute ischemic stroke requires timely reperfusion therapy.
- Endovascular therapy is a key treatment for select stroke patients.
- Accurate patient selection is crucial for optimizing endovascular therapy outcomes.
Purpose of the Study:
- To evaluate the effectiveness of computed tomographic (CT) perfusion imaging in selecting patients for endovascular therapy.
- To determine if CT perfusion can identify patients who benefit from treatment up to 18 hours after stroke symptom onset.
Main Methods:
- A multicenter cohort study included acute stroke patients undergoing endovascular therapy.
- Patients were assessed using baseline CT perfusion to identify a "target mismatch" profile (small core, large penumbra).
- Reperfusion was confirmed by follow-up imaging, and clinical outcomes were evaluated based on NIH Stroke Scale (NIHSS) improvement.
Main Results:
- Out of 190 included patients, 89% achieved reperfusion.
- Patients with the CT perfusion "target mismatch" profile showed significantly higher rates of favorable clinical response (83% vs. 44%).
- This association between reperfusion and favorable outcome was consistent in patients treated within 6 hours and those treated after 6 hours.
Conclusions:
- CT perfusion's "target mismatch" profile is robustly associated with good outcomes after endovascular reperfusion in stroke patients treated up to 18 hours.
- These findings support conducting a randomized trial for endovascular therapy in this extended time window.
- CT perfusion is a valuable tool for patient selection in late-window stroke treatment.

